On the afternoon of Dec 5, Genova Biotech (Changzhou) Co., Ltd. signed the Round B financing agreement worth 50 million USD with Tasly Holding Group and BVCF.
Zhou Bin, member of the Standing Committee of CPC Changzhou Municipal Committee and Secretary of CPC Xinbei District Committee, attended the signing ceremony.
Tasly Holding Group is a high-tech international enterprise specializing in health care, medical treatment and health service, which was listed on Shanghai Stock Exchange in 2002.
Genova Biotech is a high-tech enterprise located in Changzhou Life and Health Industrial Park, mainly engaged in the research and manufacturing of insulin analog products. In 2014, it signed the Round A financing agreement worth 20 million USD with BVCF. The 50 million USD financed in Round B will be used in the industrialization of insulin products.
掃一掃在手機打開當前頁  |
